Welcome Intercept Pharmaceuticals to OAC's Chairman's Council!The OAC is excited to welcome a brand new member to our honorary Chairman’s Council of our Membership Community – Intercept Pharmaceuticals!

Intercept Pharmaceuticals had pledged their support at the SILVER LEVEL of our Chairman’s Council and has partnered with the OAC to help improve the lives of individuals affected by obesity through awareness, education, advocacy and support. We are excited to have them on board as we grow the diversity of our supporter base and collaborate with other stakeholders and influencers to improve obesity care, education and treatment.

About Intercept Pharmaceuticals 

An innovative bio-pharmaceutical company with a focus on treating progressive non-viral liver diseases, Intercept Pharmaceuticals shares in the OAC’s mission of putting patients first at the center of their healthcare.

Their partnership with the OAC is important because obesity is associated with more than 30 health conditions and chronic diseases, some of which are connected to the liver such as NASH (Nonalcoholic steatohepatitis). Just like the OAC, Intercept Pharmaceuticals is committed to helping patients access disease education, treatment support and financial options.

To learn more about them, CLICK HERE.

OAC Chairman’s Council

The OAC is honored to have the support of Intercept Pharmaceuticals and we welcome any individual, organization or company who wishes to join our highest level of OAC Community Membership! The OAC’s Chairman’s Council is a powerful way to give back to our cause and play an integral role in helping us continue our initiatives and serve individuals affected by obesity. We offer various levels of giving within the Council which showcase the generous support of our partnering individuals and organizations, as well as the diversity of our supporter base.

To learn more about the OAC’s Chairman’s Council or to join today, CLICK HERE.